AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03652103 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound Guided Erector Spinae Plane Block Catheterisation
Description: After receiving general anesthesia, patients will positioned prone. Before operation begins, ESP block catheter will be applied with ultrasound guidance to the same level as surgeon's incision.
Study NCT03652103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% Injectable Solution
Description: Perineural Injection
Study NCT02782481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ND0612
Study NCT02782481 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00781326 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Nimodipine
Description: Nimodipine will be initiated at one, 30-mg tablet three times a day for 1 week, increased to 2 tablets three times a day for 1 week, and then increased to three tablets three times a day for the remaining 30 weeks of the study. Participants who cannot tolerate the maximum dose of 270 mg/day will be maintained at the highest tolerable dose.
Study NCT02083770 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cancer Clinical Trials Education Program
Description: Hispanic Americans are underrepresented in cancer clinical trials. The purpose of this study is to develop and test programs designed to reduce barriers and increase facilitators associated with cancer clinical trials participation for Hispanic Americans.
Study NCT02083770 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Cancer Clinical Trials Education Program
Description: Hispanic Americans are underrepresented in cancer clinical trials. The purpose of this study is to develop and test programs designed to reduce barriers and increase facilitators associated with cancer clinical trials participation for Hispanic Americans.
Study NCT00781326 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Placebo will be given in doses matching those of nimodipine.
Study NCT03028376 — intervention group
Intervention type: OTHER
Intervention: Blood sampling
Description: Blood sampling from peripheral venous catheter routinely inserted in trauma patients during transportation
Study NCT02067013 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ranibizumab
Description: Subjects in the Ranibizumab arm will receive an injection of drug within 2 weeks prior to their surgery.
Study NCT02067013 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No Ranibizumab
Description: Subjects in the control arm will NOT receive an injection of drug within 2 weeks prior to their surgery.
Study NCT02634658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Ultrasound
Description: Ultrasound will be performed using a linear-array transducer with standardized gain and varying depth based on the amount of overlying soft tissue and muscle size. The subjects will be examined in the supine position with extended limbs and relaxed muscles. We will perform bilateral scans of the biceps, anterior forearm, and anterior thigh at standardized sites. For muscle echogenicity measurements, we will scan the same muscles at the same points.
Study NCT02634658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nerve Conduction Study
Description: Nerve Conduction Studies will be performed using a Nicolet EDX using standard procedures. Repetitive stimulation of the median motor nerve are performed in all subjects. Bilateral sural, radial and median sensory nerves will be analyzed. We will only perform surface, not subdermal sensory recordings. The bilateral peroneal, tibial and median motor responses will be recorded over extensor digitorum brevis, abductor hallucis brevis, and abductor pollicis brevis muscles. The peroneal motor nerve will be stimulated at the fibular head and lateral popliteal fossa, recording from the tibialis anterior muscle. The compound motor action potential (CMAP) responses will be elicited from standard distal and proximal sites.
Study NCT02634658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electromyography
Description: EMG studies will be performed using standard precautions. Insertional activity, spontaneous activity, motor unit potential (MUP) morphology and recruitment/activation pattern will be recorded from some combination of the deltoid, triceps, biceps, first dorsal interosseous, abductor pollicis brevis, iliopsoas, vastus medialis, and tibialis anterior muscles. The specific muscles studied for each patient will vary according to the patient's level of consciousness and ability to activate the muscles either voluntarily or during spontaneous limb movement. If possible, we will try to examine 3 unilateral upper extremity and 3 unilateral lower extremity muscles. If a patient is not able to volitionally participate in EMG testing (by contracting their muscles on command), we will analyze insertional/spontaneous activity and potentially morphology/recruitment (e.g. stroking the sole of the foot to stimulate contraction of the tibialis anterior).
Study NCT02416323 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: AIM HI Training
Study NCT01747980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRX-112
Description: Single dose level, four doses per cohort
Study NCT03717337 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single visit pulp regeneration
Description: Access cavity, disinfection, preparing and injecting platelet rich plasma, and restoring the tooth all done in one visit.
Study NCT03717337 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Two visit pulp regeneration
Description: first visit : access, disinfection and placing calcium hydroxide as intracanal medicament second visit: re opening of tooth, preparing and injecting platelet rich plasma and restoring the tooth.
Study NCT02424916 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Melanoma antigens-specific CD8+ T lymphocytes
Description: The intervention uses an autologous somatic cell therapy medicinal product. It consists in the intravenous injection of melanoma antigens (Melan-A and MELOE-1) - specific CD8+ T lymphocytes followed by subcutaneous injections of Proleukin.
Study NCT03400397 — intervention group
Intervention type: OTHER
Intervention: Cool Kids programme
Description: A manualised cognitive behavioural treatment programme that consists of 10 session within 12-16 weeks each lasting 2 hours.
Study NCT02717091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX
Study NCT02717091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine + nab-paclitaxel
Study NCT04641468 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: DCB
Description: OCT technical guidance: if B-type or C-type dissection can be seen, Oct should be used for further evaluation, and des treatment should be conducted if necessary
Study NCT04493099 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alvocidib Hydrochloride
Description: Given IV
Study NCT04493099 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Given IV
Study NCT04493099 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT02285452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zingiberis Rhizoma plv.
Study NCT02658851 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: J-Plasma
Description: Bovie Medical Corporation's J-Plasma® helium based plasma technology is a hemostatic tool for the cutting, coagulation, and ablation of soft tissue.
Study NCT01714024 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zimmer Trabecular Metal Test Cylinder
Description: For all subjects 2 titanium and 2 trabecular 2.9-3.0 mm x 5 mm test cylinders will be implanted in alveolar bone. One of each type will be removed at 2 weeks. The remaining two will be removed at 4 weeks.
Study NCT02285452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sinapis nigrea semen
Study NCT01714024 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zimmer Titanium Test Cylinder
Description: For all subjects 2 titanium and 2 trabecular 2.9-3.0 mm x 5 mm test cylinders will be implanted in alveolar bone. One of each type will be removed at 2 weeks. The remaining two will be removed at 4 weeks.
Study NCT01040611 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Patients who fit the inclusion criteria were random assigned to either experimental or control group. Patients in experimental group could choose a piece of CD and listen to music with earphone for 30 minutes. Patients in control group just rest for 30 minutes. The procedure was implemented once a day, and sustained for total 5 days.
Study NCT04255095 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: experiment
Description: Treatment was randomly selected according to preoperative grouping. After ERCP, naso-pancreatic drainage was chosen as treatment。
Study NCT04255095 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: Treatment was randomly selected according to preoperative grouping. After ERCP, nasobiliary drainage was chosen as treatment。
Study NCT02477384 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 8mm-TIPS
Study NCT02477384 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic variceal ligation
Study NCT02477384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propranolol
Study NCT02477384 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 8mm ePTFE-covered stent
Study NCT02285452 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03541798 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positions of patients for combined spinal-epidural anesthesia
Description: Patients in groups will be positioned according to the study groups for performing combined spinal epidural anesthesia.
Study NCT03541798 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: positions of patients for combined spinal-epidural anesthesia
Description: Patients in groups will be positioned according to the study groups for performing combined spinal epidural anesthesia.
Study NCT03541798 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Combined spinal epidural anesthesia
Description: After positioning, a combined spinal epidural anesthesia (CSE) will be applied using a CSE Tuohy Needle (18 G) and 27 G Whitacre spinal needle via needle - through needle technique. The epidural space will be located with loss of resistance to saline. 3 ml hyperbaric bupivacaine 0.5% (15 mg) will be given for spinal anesthesia after identification of subarachnoidal space.
Study NCT03541798 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined spinal epidural anesthesia
Description: After positioning, a combined spinal epidural anesthesia (CSE) will be applied using a CSE Tuohy Needle (18 G) and 27 G Whitacre spinal needle via needle - through needle technique. The epidural space will be located with loss of resistance to saline. 3 ml hyperbaric bupivacaine 0.5% (15 mg) will be given for spinal anesthesia after identification of subarachnoidal space.
Study NCT03372018 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Promotora-led Intervention (PLI)
Description: Behavioral life-style program with cognitive-behavioral content lead by a team of trained community health workers (called promotoras) with the following principal goals - encouraging participants to lose 7% of their total weight and complete 150 minutes of moderate physical activity per week.
Study NCT03372018 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care (UC)
Description: Participants in this arm will be given educational materials in spanish discussing mental health and diabetes prevention.
Study NCT01847625 — intervention group
Intervention type: OTHER
Intervention: simulator
Study NCT04095819 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Middle Meningeal Artery procedure
Description: Seal off the blood supply to the middle meningeal artery to prevent growth of the Subdural Hematoma
Study NCT04095819 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Surgery
Description: Drainage of Subdural Hematoma using Craniotomy or Burr Hole
Study NCT02034227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SG2000
Description: intravenous doses given on Days 1, 2, and 3 of each 21-day cycle (1 to 6 cycles).
Study NCT02079389 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lap+Lus
Description: In the standard arm (Lap) the conditions at the abdomen is only assessed by laparoscopy immediately prior to the resection. In the intervention arm the intra-abdominal conditions are also assessed by laparoscopy, but then supplemented with a laparoscopic ultrasound examination of the primary tumor, liver and retroperitoneum.~All patients are given an CT scan of the abdomen after 3 months.
Study NCT00160446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asoprisnil
Description: 5mg Tablet, oral Daily for 12 weeks
Study NCT00160446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asoprisnil
Description: 10 mg Tablet, oral Daily for 12 weeks
Study NCT00160446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asoprisnil
Description: 25 mg Tablet, oral Daily for 12 weeks
Study NCT00160446 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet, oral Daily for 12 weeks
Study NCT03986918 — intervention group
Intervention type: DEVICE
Intervention: Routine Total Hip Arthroplasty
Description: Patients undergoing routine total hip arthroplasty will receive surveys regarding survivorship and outcomes.
Study NCT04454619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hand antisepsis with Clorhexidine and solution
Description: Hand antisepsis by scrub Surgical Hand scrubbing using chlorhexidine digluconate with the addition of an alcoholic solution of chlorhexidine digluconate and potassium sorbate. both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side
Study NCT04454619 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hand antisepsis with Clorhexidine and solution
Description: Hand antisepsis by scrub Surgical Hand scrubbing using chlorhexidine digluconate with the addition of an alcoholic solution of chlorhexidine digluconate and potassium sorbate. both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side
Study NCT01320826 — intervention group
Intervention type: PROCEDURE
Intervention: colonoscopy
Description: Data pertaining to all colonoscopies performed by a APC-Endo study physician over a two month period will be collected.
Study NCT03465982 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery after 8 weeks from chemoradiation treatment
Description: Minimally invasive surgery after 8 weeks from chemoradiation treatment
Study NCT03465982 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery after 12 weeks from chemoradiation treatment
Description: Minimally invasive surgery after 12 weeks from chemoradiation treatment
Study NCT01415661 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cricoid pressure
Description: The current study test by direct visual evidence the occlusion of esophageal entrance during application CP. The closure of the lumen was further demonstrated by the inability to introduce a GT into the esophagus during CP.
Study NCT03951129 — intervention group
Intervention type: PROCEDURE
Intervention: hemodialysis catheter insertion
Description: The State-Trait Anxiety Inventory (STAI) and Visual Analogue Scale (VAS) scoring will be performed after informing all groups and after the procedure
Study NCT01305135 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: azacitidine and idarubicin
Description: azacitidine:100mg, 75mg/m²/d, during 7days every 28 days (D1-D7). Idarubicin: 5mg/ml, 5mg/m²/d (palier1) or 10mg/m²/d (palier2), D8
Study NCT00679094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bowman-Birk inhibitor concentrate
Description: Given orally
Study NCT00679094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: Given orally
Study NCT00679094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT03193684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 MG
Description: subjects will receive daily dose of 25mg of empagliflozin for 3 months
Study NCT00679094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT03193684 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Placebo
Study NCT02244086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bupivacaine
Description: At the beginning of the work of effective labor maneuver randomly be allocated ( using sealed envelopes) and an outsider to the study prepared the dosage to bupivacaine 0.125% or 0.25% to be administered by epidural catheter for an anesthesiologist to disown the concentration employed. It is measured vital signs, and visual analogue scale dilatation in minutes 0,15,30,60 and 90 after being applied analgesia.
Study NCT02507115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TMAP
Description: Text messages for Alcohol Risk Reduction
Study NCT04590755 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive father-child sessions and website
Description: The Run Daddy Run intervention will consist of 5 (inter)active sessions for fathers and their children + 1 follow-up session, each session lasting 90 minutes. These sessions will be given to 8 groups of +- 13 families (fathers and their children), guided by 2 facilitators and will take place every 2 weeks, at a location in the neighborhood of fathers and children (e.g. school of the children). Additionally, a website will be available for the fathers and their children, with additional information about the project, tips and information about being active together (e.g. movement breaks, fundamental movement skills, etc.) and limiting screen time. In addition, fathers and their children will also log their goals on this website, and between two sessions (= a period of 2 weeks) they will be asked to keep track of their co-PA on this website, aiming to reach their goal.
Study NCT02507115 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Mojo Texts
Description: Motivational texts not alcohol related
Study NCT02470442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane/Desflurane
Description: Anesthesia induced with sevoflurane and anesthetic maintenance with desflurane
Study NCT02470442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: Anesthesia induced with sevoflurane and anesthetic maintenance with sevoflurane
Study NCT03653429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic Acid
Description: administered prior to surgical incision
Study NCT03653429 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: administered prior to surgical incision
Study NCT03460002 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Measles vaccine
Description: A measles vaccine prequalified from the World Health Organization will be administered in one dose by deep subcutaneous injection into the left subscapular region by a local nurse.
Study NCT03460002 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Oral polio vaccine
Description: A bivalent oral polio vaccine prequalified by the World Health Organization will be administered in one or two doses directly into the mouth of the vaccinee with two drops per dose by a local nurse.
Study NCT03591692 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACAF surgery
Description: The main surgical procedures include discectomy of the involved levels, thinning of the anterior part of the involved vertebrae, intervertebral cages, anterior plate and screws installation, bilateral osteotomies of the vertebrae, and antedisplacement of the vertebrae-OPLL complex
Study NCT03591692 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: ACCF surgery
Description: Removal of the vertebral body，exposed ossification of the posterior longitudinal ligament，and then removed
Study NCT00743353 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F-18 RGD-K5
Description: Study Drug F-18 RGD-K5 administered for diagnostic PET Imaging to be observed for a maximum of 4 hours, followed by 24 hour follow up
Study NCT01739465 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Self expanding metallic stent (SEMS)
Description: Self expanding metallic stent
Study NCT02566967 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: tofacitinib
Description: oral tofacitinib will be taken 2 times daily
Study NCT04483427 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Nalbuphine, ketorolac, accufuser
Description: multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser)
Study NCT03855462 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MCT oil injection
Description: The patient treatment is the classical surgical procedure which is used for retinal detachment with MCT oil :~* Vitrectomy, then flattened retina, and finally MCT injection in place of the vitreous.~* MCT ablation after 4 to 6 weeks (after effective retinopexy)~* after MCT ablation, total follow-up duration by patient is 6 months.